Position in SEER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$94,608
-$1,272 QoQ
Shares Held
56,993
-0.1% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 59 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SEER ranks #314 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in SEER
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,608 | 56,993 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $95,880 | 57,072 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $105,360 | 57,574 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $127,575 | 58,791 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $167,214 | 78,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $149,081 | 88,214 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $349,588 | 151,337 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $252,013 | 127,926 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $154,496 | 91,962 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $275,942 | 145,233 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $494,111 | 254,697 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $339,810 | 153,761 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $311,435 | 72,936 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $344,778 | 89,321 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $278,278 | 47,979 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $195,310 | 25,234 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $307,878 | 34,400 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $548,074 | 35,963 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $939,724 | 41,198 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $888,041 | 25,718 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,295,727 | 39,528 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,671,468 | 33,416 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,964 | 35 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||